KING-JONES HEIDY (See Remarks) sold 90.9% of their position (28.40K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.48M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+28K
Price / share
$14.50
Trade value
$405.99K
% of position
Common Stock
Shares
−4.84K
Price / share
$86.40
Trade value
$418.61K
% of position
Common Stock
Shares
−16.55K
Price / share
$87.20
Trade value
$1.44M
% of position
Common Stock
Shares
−6.21K
Price / share
$88.17
Trade value
$547.18K
% of position
Common Stock
Shares
−400.00
Price / share
$89.38
Trade value
$35.75K
% of position
Common Stock
Shares
+400.00
Price / share
$14.50
Trade value
$5.80K
% of position
Common Stock
Shares
−400.00
Price / share
$90.00
Trade value
$36K
% of position
Net shares
+0.00
Net value
-$2.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +28K | $14.50 | $405.99K | 984.1% | 2.85K | 30.84K |
| Common Stock Direct | 9/1/2026 | S · Sale | −4.84K | $86.40 | $418.61K | 15.7% | 30.84K | 26K |
| Common Stock Direct | 9/1/2026 | S · Sale | −16.55K | $87.20 | $1.44M | 63.6% | 26K | 9.45K |
| Common Stock Direct | 9/1/2026 | S · Sale | −6.21K | $88.17 | $547.18K | 65.7% | 9.45K | 3.25K |
| Common Stock Direct | 9/1/2026 | S · Sale | −400.00 | $89.38 | $35.75K | 12.3% | 3.25K | 2.85K |
| Common Stock Direct | 9/2/2026 | M · Option Exercise | +400.00 | $14.50 | $5.80K | 14.1% | 2.85K | 3.25K |
| Common Stock Direct | 9/2/2026 | S · Sale | −400.00 | $90.00 | $36K | 12.3% | 3.25K | 2.85K |
| Total | +0.00 | -$2.07M | ||||||
Stock Option (Right to Buy)
Common Stock
28K shares
Shares
−28K
Strike price
14.50
Held after
511.81K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
400.00 shares
Shares
−400.00
Strike price
14.50
Held after
511.41K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock28K shares | 9/1/2026 | M · Option Exercise | −28K | 14.50 | — | 511.81K |
| Stock Option (Right to Buy) Direct | Common Stock400.00 shares | 9/2/2026 | M · Option Exercise | −400.00 | 14.50 | — | 511.41K |